🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study is: To evaluate the tolerance of lanthanum polystyren...
Status
Unknown
Location
The First Hospital of Jilin University
Start Date
2020-10-21
Trial ID
NCT04440696
Treatments Being Tested
Safety, tolerability, pharmacokinetics, and pharmacodynamics of JMKX003002 ...
Status
Unknown
Location
Huashan Hospital Fudan University
Start Date
2023-05-09
Trial ID
NCT05907382
The purpose of this study is to test the safety of multiple doses of a Q-GR...
Status
Unknown
Location
University of Louisville Clinical Trials Unit
Start Date
2022-06-15
Trial ID
NCT05437029
Treatments Being Tested
This Phase 1 open-label study enrolls 24 healthy Chinese adults to investig...
Status
Recruiting
Location
Shanghai Xuhui Central Hospital
Start Date
2026-07-30
Trial ID
NCT07679113
Treatments Being Tested
Asthma is a chronic inflammatory bronchial disorder with three distinct com...
Status
Completed
Location
Charité Research Organisation GmbH
Start Date
2012-12
Trial ID
NCT01743768
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Recruiting
Location
Nucleus Network
Start Date
2025-10-10
Trial ID
NCT07029932
This phase I clinical study is a phase I clinical study on the safety, tole...
Status
Unknown
Location
The first hospital of Jilin University
Start Date
2022-07-19
Trial ID
NCT05576584
Treatments Being Tested
To characterize the pharmacokinetics of LCI699 following a single oral dose...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-11-06
Trial ID
NCT02399202
Treatments Being Tested
The purpose of this study is to explore the safety and tolerability of AZD5...
Status
Completed
Location
Research Site
Start Date
2010-01
Trial ID
NCT01051505
The overall study design includes two parts, Part A and Part B. Part A eva...
Status
Completed
Location
Academisch Medisch Centrum (AMC)
Start Date
2008-06
Trial ID
NCT01211626